AbbVie reaffirms Q3 adjusted EPS guidance at $3.84-$3.88
AbbVie has affirmed its Q3 adjusted EPS guidance of $3.84-$3.88, unchanged from its prior range, versus a $3.84 analyst estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.